Evidence map›Paper›PMID 23739740›Full record

ArticleInternational journal of molecular medicine2013

Induction of apoptosis and the regulation of ErbB signaling by laminarin in HT-29 human colon cancer cells.

Hee-Kyoung Park, In-Hye Kim, Joongkyun Kim, Taek-Jeong Nam

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Integrated Network Pharmacology Analysis andMolecules (Basel, Switzerland) · 2021
    Article
  17. Identification ofAnnals of translational medicine · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hee-Kyoung ParkDepartment of Food and Life Science, Pukyong National University, Nam-gu, Busan 608-737, Republic of Korea.
In-Hye Kim
Joongkyun Kim
Taek-Jeong Nam
Pukyong National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laminarin, found in marine brown algae, is used as a carbohydrate reserve for phytoplankton; however, it is also used in traditional Chinese medicine, and has been shown to have several biological activities, including anticancer activities. In this study, we examined the mechanisms through which laminarin from Laminaria digitata induces apoptosis in HT-29 colon cancer cells, as well as the involvement of the ErbB signaling pathway. Cell viability assay revealed that laminarin induced cell death in a dose-dependent manner. Cell cycle analysis revealed that laminarin increased the percentage of cells in the sub-G1 and G2-M phase. Western blot analysis demonstrated that laminarin inhibited the heregulin-stimulated phosphorylation of ErbB2. A decrease in cellular proliferation was also observed; this was found to be dependent on ErbB, which activates c-Jun N-terminal kinase. These findings demonstrate the important role of the epidermal growth factor receptor in colon cancer tumorigenesis, and suggest the potential of laminarin as a bio-functional food with anticancer effects on human colon cancer.

Indexed as

Antineoplastic AgentsApoptosisCell CycleCell Cycle ProteinsCell Line, TumorColonic NeoplasmsErbB ReceptorsGene Expression Regulation, NeoplasticGlucansHT29 CellsHumansMembrane Potential, MitochondrialNeuregulin-1PhosphorylationPolysaccharidesProto-Oncogene Proteins c-aktAntineoplastic AgentsCell Cycle ProteinsEGFR protein, humanErbB ReceptorsGlucanslaminaranNeuregulin-1PolysaccharidesProto-Oncogene Proteins c-akt

Identifiers

PMID23739740
PMCPMC3776715
OpenAlexW2092532047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.